ES2088820A1 - Anticuerpos monoclonales antineumolisina. - Google Patents

Anticuerpos monoclonales antineumolisina.

Info

Publication number
ES2088820A1
ES2088820A1 ES09400265A ES9400265A ES2088820A1 ES 2088820 A1 ES2088820 A1 ES 2088820A1 ES 09400265 A ES09400265 A ES 09400265A ES 9400265 A ES9400265 A ES 9400265A ES 2088820 A1 ES2088820 A1 ES 2088820A1
Authority
ES
Spain
Prior art keywords
antipneumolysin
monoclonal antibodies
pneumolysin
antibodies
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09400265A
Other languages
English (en)
Other versions
ES2088820B1 (es
Inventor
Los Toyos Gonzalez Juan Ram De
Garcia Francisco J Mendez
Valdes Fernando Vazquez
Aparicio Jesus Fernandez
Gutierrez Ana Fleites
Romeu Carlos Hardisson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Oviedo
Original Assignee
Universidad de Oviedo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Oviedo filed Critical Universidad de Oviedo
Priority to ES9400265A priority Critical patent/ES2088820B1/es
Priority to PCT/ES1994/000135 priority patent/WO1995016711A1/es
Priority to EP95903822A priority patent/EP0687688A1/en
Publication of ES2088820A1 publication Critical patent/ES2088820A1/es
Application granted granted Critical
Publication of ES2088820B1 publication Critical patent/ES2088820B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ANTICUERPOS MONOCLONALES ANTINEUMOLISINA. SE SUMINISTRAN HIBRIDOMAS ESTABLES MONOCLONALES ESPECIFICOS PARA LA NEUMOLISINA QUE: 1) RECONOCEN EPITOPOS DISTINTOS EN LA MOLECULA DE NEUMOLISINA; Y 2) NEUTRALIZAN SU ACCION HEMOLITICA IN VITRO. ESTOS ANTICUERPOS, FRAGMENTOS DERIVADOS DE ELLOS O FORMAS MODIFICADAS DE TODOS ELLOS, TIENEN APLICACIONES DIVERSAS, INCLUYENDO LAS DIAGNOSTICAS, PROFILACTICAS Y/O TERAPEUTICAS.
ES9400265A 1993-12-17 1994-02-14 Anticuerpos monoclonales antineumolisina. Expired - Fee Related ES2088820B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9400265A ES2088820B1 (es) 1994-02-14 1994-02-14 Anticuerpos monoclonales antineumolisina.
PCT/ES1994/000135 WO1995016711A1 (es) 1993-12-17 1994-12-17 Anticuerpos contra la neumolisina y sus aplicaciones
EP95903822A EP0687688A1 (en) 1993-12-17 1994-12-17 Antibodies against pneumolysine and their applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9400265A ES2088820B1 (es) 1994-02-14 1994-02-14 Anticuerpos monoclonales antineumolisina.

Publications (2)

Publication Number Publication Date
ES2088820A1 true ES2088820A1 (es) 1996-09-16
ES2088820B1 ES2088820B1 (es) 1997-05-16

Family

ID=8285199

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9400265A Expired - Fee Related ES2088820B1 (es) 1993-12-17 1994-02-14 Anticuerpos monoclonales antineumolisina.

Country Status (1)

Country Link
ES (1) ES2088820B1 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021305A1 (en) * 1992-04-09 1993-10-28 Global Tek Diagnostics (Canada) Inc. MONOCLONAL ANTIBODY TO CELL SURFACE PROTEIN OF THE BACTERIUM $i(STREPTOCOCCUS PNEUMONIAE)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021305A1 (en) * 1992-04-09 1993-10-28 Global Tek Diagnostics (Canada) Inc. MONOCLONAL ANTIBODY TO CELL SURFACE PROTEIN OF THE BACTERIUM $i(STREPTOCOCCUS PNEUMONIAE)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATON J.C. et al. "Molecular analysis of the pathogenicity of Streptococcus pneumoniae: The Role of Pneumococcal Proteins" Annual Review Microbiology. 1993. Vol. 47, pßginas 89-115 *

Also Published As

Publication number Publication date
ES2088820B1 (es) 1997-05-16

Similar Documents

Publication Publication Date Title
WO1998025965A3 (en) Peptides and compounds that bind to the thrombopoietin receptor
EP0552296A4 (en) Mouse monoclonal antibodies
CA2223449A1 (en) Peptides and compounds that bind to the thrombopoietin receptor
WO2001014424A3 (en) Human ctla-4 antibodies and their uses
MY113497A (en) Peptides and compounds that bind to a receptor
AU8083594A (en) Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
DE69429095D1 (de) Humanisierte antikoerper
EP0724456A4 (en) ANTIBODIES AGAINST CD40
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
HK1044159A1 (zh) 抗γ-干擾素的人化抗體
DE69332744T2 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
CY2440B1 (en) Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide.
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
ZA965565B (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits.
NZ331398A (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
AU4441393A (en) Granulocyte-binding antibody fragments, their preparation and use
ES2088820A1 (es) Anticuerpos monoclonales antineumolisina.
PL323195A1 (en) Alpha unit of human integrin beta 2
TW223019B (es)
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
HK1016482A1 (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19960916

Kind code of ref document: A1

Effective date: 19960916

FD2A Announcement of lapse in spain

Effective date: 20141120